Girish Aakalu

2019

In 2019, Girish Aakalu earned a total compensation of $798.1K as Chief Business Officer at Genocea Biosciences.

Compensation breakdown

Bonus$150,000
Non-Equity Incentive Plan$146,300
Option Awards$112,908
Salary$385,000
Other$3,850
Total$798,058

Aakalu received $385K in salary, accounting for 48% of the total pay in 2019.

Aakalu also received $150K in bonus, $146.3K in non-equity incentive plan, $112.9K in option awards and $3.9K in other compensation.

Rankings

In 2019, Girish Aakalu's compensation ranked 10,226th out of 13,971 executives tracked by ExecPay. In other words, Aakalu earned more than 26.8% of executives.

ClassificationRankingPercentile
All
10,226
out of 13,971
27th
Division
Manufacturing
4,140
out of 5,701
27th
Major group
Chemicals And Allied Products
1,581
out of 2,200
28th
Industry group
Drugs
1,354
out of 1,886
28th
Industry
Biological Products, Except Diagnostic Substances
300
out of 389
23rd
Source: SEC filing on April 20, 2020.

Aakalu's colleagues

We found two more compensation records of executives who worked with Girish Aakalu at Genocea Biosciences in 2019.

2019

William Clark

Genocea Biosciences

Chief Executive Officer

2019

Thomas Davis

Genocea Biosciences

Chief Medical Officer

News

You may also like